Unmasking a Silent Threat: Improving Pulmonary Hypertension Screening Methods for Interstitial Lung Disease Patients

被引:2
作者
Averjanovaite, Vaida [1 ]
Gumbiene, Lina [2 ]
Zeleckiene, Ingrida [1 ]
Sileikiene, Virginija [3 ]
机构
[1] Vilnius Univ, Fac Med, LT-03101 Vilnius, Lithuania
[2] Vilnius Univ, Inst Clin Med, Fac Med, Clin Cardiac & Vasc Dis, LT-03101 Vilnius, Lithuania
[3] Vilnius Univ, Inst Clin Med, Clin Chest Dis Immunol & Allergol, Fac Med, LT-03101 Vilnius, Lithuania
来源
MEDICINA-LITHUANIA | 2024年 / 60卷 / 01期
关键词
pulmonary hypertension; interstitial lung disease; cardiopulmonary exercise testing; lung function tests; echocardiography; cardiac magnetic resonance imaging; ARTERIAL-HYPERTENSION; SYSTEMIC-SCLEROSIS; ECHOCARDIOGRAPHIC-ASSESSMENT; CLINICAL-FEATURES; FIBROSIS; EMPHYSEMA; EPIDEMIOLOGY; PREVALENCE; PREDICTION; PRESSURE;
D O I
10.3390/medicina60010058
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This article provides a comprehensive overview of the latest literature on the diagnostics and treatment of pulmonary hypertension (PH) associated with interstitial lung disease (ILD). Heightened suspicion for PH arises when the advancement of dyspnoea in ILD patients diverges from the expected pattern of decline in pulmonary function parameters. The complexity of PH associated with ILD (PH-ILD) diagnostics is emphasized by the limitations of transthoracic echocardiography in the ILD population, necessitating the exploration of alternative diagnostic approaches. Cardiac magnetic resonance imaging (MRI) emerges as a promising tool, offering insights into hemodynamic parameters and providing valuable prognostic information. The potential of biomarkers, alongside pulmonary function and cardiopulmonary exercise tests, is explored for enhanced diagnostic and prognostic precision. While specific treatments for PH-ILD remain limited, recent studies on inhaled treprostinil provide new hope for improved patient outcomes.
引用
收藏
页数:19
相关论文
共 109 条
[91]   Heart rate recovery after six-minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosis [J].
Swigris, Jeffrey J. ;
Olson, Amy L. ;
Shlobin, Oksana A. ;
Ahmad, Shahzad ;
Brown, Kevin K. ;
Nathan, Steven D. .
RESPIROLOGY, 2011, 16 (03) :439-445
[92]   Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease [J].
Tan, RT ;
Kuzo, R ;
Goodman, LR ;
Siegel, R ;
Haasler, GB ;
Presberg, KW .
CHEST, 1998, 113 (05) :1250-1256
[93]   Progression of mean pulmonary arterial pressure in idiopathic pulmonary fibrosis with mild to moderate restriction [J].
Teramachi, Ryo ;
Taniguchi, Hiroyuki ;
Kondoh, Yasuhiro ;
Ando, Masahiko ;
Kimura, Tomoki ;
Kataoka, Kensuke ;
Suzuki, Atsushi ;
Furukawa, Taiki ;
Sakamoto, Koji ;
Hasegawa, Yoshinori .
RESPIROLOGY, 2017, 22 (05) :986-990
[94]   Combined pulmonary fibrosis and emphysema: effect of pulmonary rehabilitation in comparison with chronic obstructive pulmonary disease [J].
Tomioka, Hiromi ;
Mamesaya, Nobuaki ;
Yamashita, Shyuji ;
Kida, Yoko ;
Kaneko, Masahiro ;
Sakai, Hideki .
BMJ OPEN RESPIRATORY RESEARCH, 2016, 3 (01)
[95]   S100A12 as a marker of worse cardiac output and mortality in pulmonary hypertension [J].
Tzouvelekis, Argyrios ;
Herazo-Maya, Jose D. ;
Ryu, Changwan ;
Chu, Jen-Hwa ;
Zhang, Yingze ;
Gibson, Kevin F. ;
Adonteng-Boateng, Percy K. ;
Li, Qin ;
Pan, Hongyi ;
Cherry, Benjamin ;
Ahmad, Ferhaan ;
Ford, Hubert J. ;
Herzog, Erica L. ;
Kaminski, Naftali ;
Fares, Wassim H. .
RESPIROLOGY, 2018, 23 (08) :771-779
[96]   Pulmonary vascular limitation to exercise and survival in idiopathic pulmonary fibrosis [J].
van der Plas, Mart N. ;
van Kan, Coen ;
Blumenthal, Judith ;
Jansen, Henk M. ;
Wells, Athol U. ;
Bresser, Paul .
RESPIROLOGY, 2014, 19 (02) :269-275
[97]   Systemic sclerosis and its pulmonary complications in The Netherlands: an epidemiological study [J].
Vonk, M. C. ;
Broers, B. ;
Heijdra, Y. F. ;
Ton, E. ;
Snijder, R. ;
van Dijk, A. P. J. ;
van Laar, J. M. ;
Bootsma, H. ;
van Hal, P. Th W. ;
van den Hoogen, F. H. J. ;
van Daele, P. L. A. .
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (06) :961-965
[98]   C-X-C Motif Chemokine 13 (CXCL13) Is a Prognostic Biomarker of Idiopathic Pulmonary Fibrosis [J].
Vuga, Louis J. ;
Tedrow, John R. ;
Pandit, Kusum V. ;
Tan, Jiangning ;
Kass, Daniel J. ;
Xue, Jianmin ;
Chandra, Divay ;
Leader, Joseph K. ;
Gibson, Kevin F. ;
Kaminski, Naftali ;
Sciurba, Frank C. ;
Duncan, Steven R. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189 (08) :966-974
[99]  
Walsh KF, 2022, LANCET GLOB HEALTH, V10, pE476, DOI 10.1016/S2214-109X(22)00042-0
[100]   Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease [J].
Waxman, Aaron ;
Restrepo-Jaramillo, Ricardo ;
Thenappan, Thenappan ;
Ravichandran, Ashwin ;
Engel, Peter ;
Bajwa, Abubakr ;
Allen, Roblee ;
Feldman, Jeremy ;
Argula, Rahul ;
Smith, Peter ;
Rollins, Kristan ;
Deng, Chunqin ;
Peterson, Leigh ;
Bell, Heidi ;
Tapson, Victor ;
Nathan, Steven D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (04) :325-334